| mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.9 |
| mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0093 |
0.9 |
| mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |